Cargando…

Discovery of Novel Digital Biomarkers for Type 2 Diabetic Nephropathy Classification via Integration of Urinary Proteomics and Pathology

BACKGROUND: The heterogeneous phenotype of diabetic nephropathy (DN) from type 2 diabetes complicates appropriate treatment approaches and outcome prediction. Kidney histology helps diagnose DN and predict its outcomes, and an artificial intelligence (AI)-based approach will maximize clinical utilit...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucarelli, Nicholas, Yun, Donghwan, Han, Dohyun, Ginley, Brandon, Moon, Kyung Chul, Rosenberg, Avi Z., Tomaszewski, John E., Zee, Jarcy, Jen, Kuang-Yu, Han, Seung Seok, Sarder, Pinaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187347/
https://www.ncbi.nlm.nih.gov/pubmed/37205413
http://dx.doi.org/10.1101/2023.04.28.23289272
_version_ 1785042723074473984
author Lucarelli, Nicholas
Yun, Donghwan
Han, Dohyun
Ginley, Brandon
Moon, Kyung Chul
Rosenberg, Avi Z.
Tomaszewski, John E.
Zee, Jarcy
Jen, Kuang-Yu
Han, Seung Seok
Sarder, Pinaki
author_facet Lucarelli, Nicholas
Yun, Donghwan
Han, Dohyun
Ginley, Brandon
Moon, Kyung Chul
Rosenberg, Avi Z.
Tomaszewski, John E.
Zee, Jarcy
Jen, Kuang-Yu
Han, Seung Seok
Sarder, Pinaki
author_sort Lucarelli, Nicholas
collection PubMed
description BACKGROUND: The heterogeneous phenotype of diabetic nephropathy (DN) from type 2 diabetes complicates appropriate treatment approaches and outcome prediction. Kidney histology helps diagnose DN and predict its outcomes, and an artificial intelligence (AI)-based approach will maximize clinical utility of histopathological evaluation. Herein, we addressed whether AI-based integration of urine proteomics and image features improves DN classification and its outcome prediction, altogether augmenting and advancing pathology practice. METHODS: We studied whole slide images (WSIs) of periodic acid-Schiff-stained kidney biopsies from 56 DN patients with associated urinary proteomics data. We identified urinary proteins differentially expressed in patients who developed end-stage kidney disease (ESKD) within two years of biopsy. Extending our previously published human-AI-loop pipeline, six renal sub-compartments were computationally segmented from each WSI. Hand-engineered image features for glomeruli and tubules, and urinary protein measurements, were used as inputs to deep-learning frameworks to predict ESKD outcome. Differential expression was correlated with digital image features using the Spearman rank sum coefficient. RESULTS: A total of 45 urinary proteins were differentially detected in progressors, which was most predictive of ESKD (AUC=0.95), while tubular and glomerular features were less predictive (AUC=0.71 and AUC=0.63, respectively). Accordingly, a correlation map between canonical cell-type proteins, such as epidermal growth factor and secreted phosphoprotein 1, and AI-based image features was obtained, which supports previous pathobiological results. CONCLUSIONS: Computational method-based integration of urinary and image biomarkers may improve the pathophysiological understanding of DN progression as well as carry clinical implications in histopathological evaluation.
format Online
Article
Text
id pubmed-10187347
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-101873472023-05-17 Discovery of Novel Digital Biomarkers for Type 2 Diabetic Nephropathy Classification via Integration of Urinary Proteomics and Pathology Lucarelli, Nicholas Yun, Donghwan Han, Dohyun Ginley, Brandon Moon, Kyung Chul Rosenberg, Avi Z. Tomaszewski, John E. Zee, Jarcy Jen, Kuang-Yu Han, Seung Seok Sarder, Pinaki medRxiv Article BACKGROUND: The heterogeneous phenotype of diabetic nephropathy (DN) from type 2 diabetes complicates appropriate treatment approaches and outcome prediction. Kidney histology helps diagnose DN and predict its outcomes, and an artificial intelligence (AI)-based approach will maximize clinical utility of histopathological evaluation. Herein, we addressed whether AI-based integration of urine proteomics and image features improves DN classification and its outcome prediction, altogether augmenting and advancing pathology practice. METHODS: We studied whole slide images (WSIs) of periodic acid-Schiff-stained kidney biopsies from 56 DN patients with associated urinary proteomics data. We identified urinary proteins differentially expressed in patients who developed end-stage kidney disease (ESKD) within two years of biopsy. Extending our previously published human-AI-loop pipeline, six renal sub-compartments were computationally segmented from each WSI. Hand-engineered image features for glomeruli and tubules, and urinary protein measurements, were used as inputs to deep-learning frameworks to predict ESKD outcome. Differential expression was correlated with digital image features using the Spearman rank sum coefficient. RESULTS: A total of 45 urinary proteins were differentially detected in progressors, which was most predictive of ESKD (AUC=0.95), while tubular and glomerular features were less predictive (AUC=0.71 and AUC=0.63, respectively). Accordingly, a correlation map between canonical cell-type proteins, such as epidermal growth factor and secreted phosphoprotein 1, and AI-based image features was obtained, which supports previous pathobiological results. CONCLUSIONS: Computational method-based integration of urinary and image biomarkers may improve the pathophysiological understanding of DN progression as well as carry clinical implications in histopathological evaluation. Cold Spring Harbor Laboratory 2023-05-03 /pmc/articles/PMC10187347/ /pubmed/37205413 http://dx.doi.org/10.1101/2023.04.28.23289272 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.
spellingShingle Article
Lucarelli, Nicholas
Yun, Donghwan
Han, Dohyun
Ginley, Brandon
Moon, Kyung Chul
Rosenberg, Avi Z.
Tomaszewski, John E.
Zee, Jarcy
Jen, Kuang-Yu
Han, Seung Seok
Sarder, Pinaki
Discovery of Novel Digital Biomarkers for Type 2 Diabetic Nephropathy Classification via Integration of Urinary Proteomics and Pathology
title Discovery of Novel Digital Biomarkers for Type 2 Diabetic Nephropathy Classification via Integration of Urinary Proteomics and Pathology
title_full Discovery of Novel Digital Biomarkers for Type 2 Diabetic Nephropathy Classification via Integration of Urinary Proteomics and Pathology
title_fullStr Discovery of Novel Digital Biomarkers for Type 2 Diabetic Nephropathy Classification via Integration of Urinary Proteomics and Pathology
title_full_unstemmed Discovery of Novel Digital Biomarkers for Type 2 Diabetic Nephropathy Classification via Integration of Urinary Proteomics and Pathology
title_short Discovery of Novel Digital Biomarkers for Type 2 Diabetic Nephropathy Classification via Integration of Urinary Proteomics and Pathology
title_sort discovery of novel digital biomarkers for type 2 diabetic nephropathy classification via integration of urinary proteomics and pathology
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187347/
https://www.ncbi.nlm.nih.gov/pubmed/37205413
http://dx.doi.org/10.1101/2023.04.28.23289272
work_keys_str_mv AT lucarellinicholas discoveryofnoveldigitalbiomarkersfortype2diabeticnephropathyclassificationviaintegrationofurinaryproteomicsandpathology
AT yundonghwan discoveryofnoveldigitalbiomarkersfortype2diabeticnephropathyclassificationviaintegrationofurinaryproteomicsandpathology
AT handohyun discoveryofnoveldigitalbiomarkersfortype2diabeticnephropathyclassificationviaintegrationofurinaryproteomicsandpathology
AT ginleybrandon discoveryofnoveldigitalbiomarkersfortype2diabeticnephropathyclassificationviaintegrationofurinaryproteomicsandpathology
AT moonkyungchul discoveryofnoveldigitalbiomarkersfortype2diabeticnephropathyclassificationviaintegrationofurinaryproteomicsandpathology
AT rosenbergaviz discoveryofnoveldigitalbiomarkersfortype2diabeticnephropathyclassificationviaintegrationofurinaryproteomicsandpathology
AT tomaszewskijohne discoveryofnoveldigitalbiomarkersfortype2diabeticnephropathyclassificationviaintegrationofurinaryproteomicsandpathology
AT zeejarcy discoveryofnoveldigitalbiomarkersfortype2diabeticnephropathyclassificationviaintegrationofurinaryproteomicsandpathology
AT jenkuangyu discoveryofnoveldigitalbiomarkersfortype2diabeticnephropathyclassificationviaintegrationofurinaryproteomicsandpathology
AT hanseungseok discoveryofnoveldigitalbiomarkersfortype2diabeticnephropathyclassificationviaintegrationofurinaryproteomicsandpathology
AT sarderpinaki discoveryofnoveldigitalbiomarkersfortype2diabeticnephropathyclassificationviaintegrationofurinaryproteomicsandpathology